Kevin Balthaser

ACRS

Kevin Balthaser serves as Chief Financial Officer at Aclaris Therapeutics, Inc. (ACRS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$75.0K

Total Sells

11 trades

$260.7K

Net Position

Net Seller

$185.8K

Companies Traded

ACRS

Active Period

Mar 2023 – Feb 2026

12 total trades

Most Recent

Sell ACRS

Feb 3, 2026 · $22.4K

Kevin Balthaser's Insider Trading at Aclaris Therapeutics, Inc. (ACRS)

Buys

1 · $75.0K

Sells

11 · $260.7K

Total Shares Bought

9,490

Total Shares Sold

89,260

ACRS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Feb 3, 2026	Sell	6,449	$3.47	$22.4K
Feb 1, 2026	Sell	4,984	$3.51	$17.5K
Dec 31, 2025	Sell	26,645	$2.99	$79.6K
Mar 1, 2025	Sell	727	$1.99	$1.4K
Feb 1, 2025	Sell	5,816	$2.48	$14.4K
Dec 31, 2024	Sell	38,221	$2.48	$94.8K
Sep 1, 2024	Sell	286	$1.18	$337.48
Mar 1, 2024	Sell	1,417	$1.24	$1.8K
Jan 1, 2024	Sell	2,536	$1.05	$2.7K
Sep 6, 2023	Buy	9,490	$7.90	$75.0K
Sep 1, 2023	Sell	285	$7.90	$2.3K
Mar 1, 2023	Sell	1,894	$12.45	$23.6K

Related Insiders

Braden Michael Leonard

10 percent owner

ACRSSell · Apr 27, 2026

James Loerop

Chief Business Officer

ACRSSell · Feb 3, 2026

Neal Walker

CEO

ACRSSell · Feb 3, 2026

Explore More Insider Trading Data

ACRS Insider Trading Activity

View all insider trades at Aclaris Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity